Section 190. Requirements for drug storage, dispensing, destruction, and records for all establishments, full ser  


Latest version.
  • A. All drugs shall be maintained, administered, dispensed, prescribed and destroyed in compliance with state and federal laws, which include the Drug Control Act (§ 54.1-3400 et seq. of the Code of Virginia), applicable parts of the federal Food, Drug, and Cosmetic Control Act (21 USC § 301 et seq.), the Prescription Drug Marketing Act (21 USC § 301 et seq.), and the Controlled Substances Act (21 USC § 801 et seq.), as well as applicable portions of Title 21 of the Code of Federal Regulations.

    B. All repackaged tablets and capsules dispensed for companion animals shall be in approved safety closure containers, except safety caps shall not be required when any person who requests that the medication not have a safety cap, or in such cases in which the medication is of such form or size that it cannot be reasonably dispensed in such containers (e.g., topical medications, ophthalmic, or otic). A client request for nonsafety packaging shall be documented in the patient record.

    C. All drugs dispensed for companion animals shall be labeled with the following:

    1. Name and address of the facility;

    2. Name of client;

    3. Animal identification;

    4. Date dispensed;

    5. Directions for use;

    6. Name, strength (if more than one dosage form exists), and quantity of the drug; and

    7. Name of the prescribing veterinarian.

    D. All drugs shall be maintained in a secured manner with precaution taken to prevent diversion.

    1. All Schedule II through V drugs shall be maintained under lock at all times, with access to the veterinarian or veterinary technician only, but not to any unlicensed personnel.

    2. Whenever a veterinarian discovers a theft or any unusual loss of Schedule II, III, IV, or V drugs, he shall immediately report such theft or loss to the Board of Veterinary Medicine and to the U.S. Drug Enforcement Administration.

    E. Schedule II, III, IV, and V drugs shall be destroyed by (i) transferring the drugs to another entity authorized to possess or provide for proper disposal of such drugs or (ii) destroying the drugs by burning in an incinerator that is in compliance with applicable local, state, and federal laws and regulations. If Schedule II through V drugs are to be destroyed, a DEA drug destruction form shall be fully completed and used as the record of all drugs to be destroyed. A copy of the destruction form shall be retained at the veterinarian practice site with other inventory records.

    F. The drug storage area shall have appropriate provision for temperature control for all drugs and biologics, including a refrigerator with the interior thermometer maintained between 36°F and 46°F. Drugs stored at room temperature shall be maintained between 59°F and 86°F. The stock of drugs shall be reviewed frequently and removed from the working stock of drugs at the expiration date.

    G. A distribution record shall be maintained in addition to the patient's record, in chronological order, for the administration and dispensing of all Schedule II-V drugs.

    This record is to be maintained for a period of two years from the date of transaction. This record shall include the following:

    1. Date of transaction;

    2. Drug name, strength, and the amount dispensed, administered and wasted;

    3. Client and animal identification; and

    4. Identification of the veterinarian authorizing the administration or dispensing of the drug.

    H. Original invoices for all Schedule II, III, IV and V drugs received shall be maintained in chronological order on the premises where the stock of drugs is held and actual date of receipt is noted. Invoices for Schedule II drugs shall be maintained separately from other records. All drug records shall be maintained for a period of two years from the date of transaction.

    I. A complete and accurate inventory of all Schedule II, III, IV and V drugs shall be taken, dated, and signed on any date that is within two years of the previous biennial inventory. Drug strength must be specified. This inventory shall indicate if it was made at the opening or closing of business and shall be maintained on the premises where the drugs are held for two years from the date of taking the inventory.

    J. Veterinary establishments in which bulk reconstitution of injectable, bulk compounding or the prepackaging of drugs is performed shall maintain adequate control records for a period of one year or until the expiration, whichever is greater. The records shall show the name of the drug(s) used; strength, if any; date repackaged; quantity prepared; initials of the veterinarian verifying the process; the assigned lot or control number; the manufacturer's or distributor's name and lot or control number; and an expiration date.

Historical Notes

Derived from VR645-01-1 § 4.2, eff. June 10, 1987; amended, Volume 06, Issue 26, eff. October 31, 1990; Volume 12, Issue 09, eff. February 21, 1996; Volume 15, Issue 05, eff. December 23, 1998; Errata, 15:9 VA.R. 1276 January 18, 1999; amended, Virginia Register Volume 19, Issue 09, eff. March 1, 2003; Volume 26, Issue 04, eff. November 25, 2009; Volume 28, Issue 05, eff. December 22, 2011.

Statutory Authority

§ 54.1-2400 of the Code of Virginia.